Search Results - Michael Erdmann
- Showing 1 - 14 results of 14
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Avelumab mediates antibody‐dependent cellular cytotoxicity against monocyte‐derived dendritic cells through natural killer cells by Tatjana Sauerer, Franziska Bremm, Amke C. Beenen, Lukas Heger, Diana Dudziak, Naomi C. Bosch, Michael Erdmann, Carola Berking, Niels Schaft, Jan Dörrie
Published 2025Artigo -
8
Twelve-year survival and immune correlates in dendritic cell–vaccinated melanoma patients by Stefanie Groß, Michael Erdmann, Ina Haendle, Steve Voland, Thomas G. Berger, Erwin Schultz, Erwin Strasser, Peter Dankerl, Rolf Janka, Stefan Schliep, Lucie Heinzerling, Karl Sotlar, Pierre G. Coulie, Gerold Schuler, Beatrice Schuler‐Thurner
Published 2017Artigo -
9
Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg by Andreas S. Baur, Manfred B. Lutz, Stephan Schierer, Luca Beltrame, Gabi Theiner, Elisabeth Zinser, Christian Ostalecki, Gordon F. Heidkamp, Ina Haendle, Michael Erdmann, Manuel Wiesinger, Waltraud Leisgang, Stefanie Groß, Ansgar J. Pommer, Eckhart Kämpgen, Diana Dudziak, Alexander Steinkasserer, Duccio Cavalieri, Beatrice Schuler‐Thurner, Gerold Schuler
Published 2013Artigo -
10
Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma by Lea Jessica Albrecht, Florentia Dimitriou, Piyush Grover, Jessica C. Hassel, Michael Erdmann, Andrea Forschner, Douglas B. Johnson, Renáta Váraljai, Georg Lodde, Jan Malte Placke, Frederik Krefting, Anne Zaremba, Selma Ugurel, Alexander Roesch, Carsten Schulz, Carola Berking, Christoph Pöttgen, Alexander M. Menzies, Georgina V. Long, Reinhard Dummer, Elisabeth Livingstone, Dirk Schadendorf, Lisa Zimmer
Published 2024Artigo -
11
Federated Learning for Decentralized Artificial Intelligence in Melanoma Diagnostics by Sarah Haggenmüller, Max Schmitt, Eva Krieghoff‐Henning, Achim Hekler, Roman C. Maron, Christoph Wies, Jochen Utikal, Friedegund Meier, Sarah Hobelsberger, Frank Friedrich Gellrich, Mildred Sergon, Axel Hauschild, Lars E. French, Lucie Heinzerling, Justin Gabriel Schlager, Kamran Ghoreschi, Max Schlaak, Franz J. Hilke, Gabriela Poch, Sören Korsing, Carola Berking, Markus V. Heppt, Michael Erdmann, Sebastian Haferkamp, Konstantin Drexler, Dirk Schadendorf, Wiebke Sondermann, Matthias Goebeler, Bastian Schilling, Jakob Nikolas Kather, Stefan Fröhling, Titus J. Brinker
Published 2024Artigo -
12
Explainable artificial intelligence in skin cancer recognition: A systematic review by Katja Hauser, Alexander Kurz, Sarah Haggenmüller, Roman C. Maron, Christof von Kalle, Jochen Utikal, Friedegund Meier, Sarah Hobelsberger, Frank Friedrich Gellrich, Mildred Sergon, Axel Hauschild, Lars E. French, Lucie Heinzerling, Justin Gabriel Schlager, Kamran Ghoreschi, Max Schlaak, Franz J. Hilke, Gabriela Poch, Heinz Kutzner, Carola Berking, Markus V. Heppt, Michael Erdmann, Sebastian Haferkamp, Dirk Schadendorf, Wiebke Sondermann, Matthias Goebeler, Bastian Schilling, Jakob Nikolas Kather, Stefan Fröhling, Daniel B. Lipka, Achim Hekler, Eva Krieghoff‐Henning, Titus J. Brinker
Published 2022Revisão -
13
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors by Nicolás Gonzalo Núñez, Fiamma Berner, Ekaterina Friebel, Susanne Unger, Nina Wyss, Julia M. Martínez Gómez, Mette-Triin Purde, Rebekka Niederer, Maximilian Porsch, Christa Lichtensteiger, Rafaela Kramer, Michael Erdmann, Christina Schmitt, Lucie Heinzerling, Marie-Therese Abdou, Julia Karbach, Dirk Schadendorf, Lisa Zimmer, Selma Ugurel, Niklas Klümper, Michael Hölzel, Laura Power, Stefanie Kreutmair, Mariaelena Capone, Gabriele Madonna, Lacin Cevhertas, Anja Heider, Teresa Amaral, Omar Hasan Ali, David Bomze, Florentia Dimitriou, Stefan Diem, Paolo A. Ascierto, Reinhard Dummer, Elke Jäger, Christoph Driessen, Mitchell P. Levesque, Willem van de Veen, Markus Joerger, Martin Früh, Burkhard Becher, Lukas Flatz
Published 2023Artigo -
14
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition by Aljosja Rogiers, Inês Pires da Silva, Chiara Tentori, Carlo Tondini, Joseph M. Grimes, Megan H. Trager, Sharon H. Nahm, Leyre Zubiri, Michael P. Manos, Peter J. Bowling, Arielle Elkrief, Neha Papneja, Maria Grazia Vitale, April A. N. Rose, Jessica S.W. Borgers, Séverine Le Roy, Joanna Mangana, Thiago Pimentel Muniz, Tim Cooksley, Jéremy Lupu, A Vaisman, Samuel D. Saibil, Marcus O. Butler, Alexander M. Menzies, Matteo S. Carlino, Michael Erdmann, Carola Berking, Lisa Zimmer, Dirk Schadendorf, Laura Pala, Paola Queirolo, Christian Posch, Axel Hauschild, Reinhard Dummer, John B.A.G. Haanen, Christian U. Blank, Caroline Robert, Ryan J. Sullivan, Paolo A. Ascierto, Wilson H. Miller, F. Stephen Hodi, Karijn P.M. Suijkerbuijk, Kerry L. Reynolds, Osama E. Rahma, Paul Lorigan, Richard D. Carvajal, Serigne Lo, Mario Mandalà, Georgina V. Long
Published 2021Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Cancer research
Immunology
Immune system
Melanoma
Cancer
Immunotherapy
Biology
Oncology
Immune checkpoint
Computer science
Nivolumab
Adverse effect
Artificial intelligence
Biochemistry
Bioinformatics
Blockade
Cell biology
Classifier (UML)
Dermatology
Disease
In vitro
Ipilimumab
Receptor
Skin cancer
Targeted therapy
2019-20 coronavirus outbreak
Antibody
Antibody-dependent cell-mediated cytotoxicity